Application Nr Approved Date Route Status External Links
NDA012541 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Uses Adjunctive Therapy And Palliative Treatment Of Inoperable, Recurrent, And Metastatic Endometrial Or Renal Carcinoma.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Medroxyprogesterone Acetate MEDROXYPROGESTERONE ACETATE ZINC5224164

Comments